Because DBC1 is involved in the inhibition of BRCA1 [22] and BRCA1/2 status is important in the development and progression of ovarian carcinomas, we investigated the immunohistochemical expression of BRCA1 in ovarian carcinomas. This evidence concerns the gene CCAR2 and ovarian carcinoma.